The Jordan Syatt Podcast Understanding Retatrutide, Building Strength vs Muscle, Pregnancy and Postpartum Nutrition, and More...
12 snips
Jan 25, 2026 They unpack retatrutide basics and emerging trial results. They debate whether GLP-1 drugs affect muscle and bone. They explain strength training versus hypertrophy and the role of progressive overload. They discuss training intensity, when all-out sessions make sense, and steroid-era contrasts. They cover pregnancy and postpartum nutrition, breastfeeding calorie priorities, and tracking intake.
AI Snips
Chapters
Transcript
Episode notes
Retatrutide Is Promising — Ask A Doctor
- Consider retatrutide as a promising next-gen GLP-1/GIP/glucagon drug but consult a medical provider first.
- Jordan plans to try it when available and will report results, but he emphasizes he is not a doctor.
Why Muscle Loss Happens With GLP-1s
- GLP-1 drugs don't inherently cause muscle loss; loss often comes from calorie deficits and not strength training.
- Jordan highlights clients who gained muscle and bone density while lifting and maintaining protein intake on GLP-1s.
Jordan's Tirzepatide Blood Work Win
- Jordan reports improved blood markers and cholesterol after low-dose tirzepatide and working with Merrick Health.
- He emphasizes personal experimentation but reiterates he's not a medical provider.